FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.
Stein L, Murugesan K, Reeser JW, Risch Z, Wing MR, Paruchuri A, Samorodnitsky E, Hoskins EL, Dao T, Smith A, Le D, Babcook MA, Chang YS, Avenarius MR, Imam M, Freud AG, Roychowdhury S.
Stein L, et al. Among authors: avenarius mr.
NPJ Precis Oncol. 2024 Sep 17;8(1):207. doi: 10.1038/s41698-024-00683-x.
NPJ Precis Oncol. 2024.
PMID: 39289482
Free PMC article.